2/5 Pharmas Market with Mike Huckman

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Pharmas Market with Mike Huckman Roche Still Gunning For Genentech February 4, 2009 at 10:51 am Posted By: Mike Huckman Shares of Swiss drugmaker Roche are trading significantly lower overseas and in over-the-counter activity here in the States after the company reported earnings.    Read More Topics:Earnings | Stock Market | Medicine | Corporate News | Mergers & Acquisitions | CEOs and CFOs | Pharmaceuticals Sectors:Health Care | Pharmaceuticals Companies:Genentech, Inc. MEDIA:PHOTO Permalink Progress For Eli Lilly & The FDA February 3, 2009 at 5:01 pm Posted By: Mike Huckman Right around the closing bell today an FDA advisory committee voted unanimously in favor of recommending approval of Eli Lilly's bloodthinner called Effient.    Read More Topics:FDA | Stock Market | Medicine | Corporate News | Pharmaceuticals Sectors:Insurance | Health Care | Pharmaceuticals Companies:Sanofi-Aventis SA | Eli Lilly and Company | Bristol-Myers Squibb Co Permalink Merck Lets Its Gardasil Down February 3, 2009 at 9:55 am Posted By: Mike Huckman Before Gardasil came to market two to three years ago, some analystys were saying it would become the biggest-selling vaccine in history. But hope and reality have turned out to be two different things.     Read More Topics:Earnings | Stock Market | Medicine | Corporate News | CEOs and CFOs | Pharmaceuticals Sectors:Health Care Equipment and Services | Health Care | Pharmaceuticals Companies:GlaxoSmithKline plc | Merck & Co Inc MEDIA:PHOTO Permalink   This email was sent to aslakchristensen.e-news-freemarket@blogger.com . Don't want to receive this feed any longer? Unsubscribe here.